Predictors Of Successful Extubation in Critically Ill Patients: Multicentre Observational Study
NCT ID: NCT03185962
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
499 participants
OBSERVATIONAL
2017-05-01
2020-08-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Volume Responsiveness Before SBT Predicts the Outcome of Mechanical Ventilation Weaning in Critically Ill Patients
NCT01867853
Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU)
NCT06391424
Prediction of Extubation Success by the Patient
NCT00448565
Prediction of Extubation Failure: A Multicenter Prospective Observational Study
NCT05069441
Unplanned-extubation in the ICU; Incidence, Characteristics and Prognosis. Success And Failure of Self-Extubation in the ICU
NCT04992117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Reintubation within 48 hours after extubation (logistic regression will be used to assess the risk factors)
Secondary Outcome Measures:
* Use of non-invasive positive pressure ventilation or nasal high flow within 48 hours after extubation.
* Risk factors for extubation failure, with quantitative variables expressed as means (standard deviation) or medians (interquartiles 25%-75%) and compared using the student t test or Wilcoxon test as appropriate
* Length of ICU and hospital stay, vital status at ICU and hospital discharge, 28-day mortality
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Successful extubation
extubated successfully
No interventions assigned to this group
Extubation failure
reintubated within 48 hours
No interventions assigned to this group
NPPV/NHF
use of non-invasive positive pressure ventilation (NPPV) or nasal high flow (NHF) within 48 hours after extubation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Extubated after successful the 30 min spontaneous breathing test using a low level of pressure support with positive end-expiratory pressure
Exclusion Criteria
* Unplanned extubation
* Extracorporeal circulation
* Patients who died within 48 hours after extubation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Osaka University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuji Fujino
Role: STUDY_CHAIR
Department of Anesthesiology and Intensive Care Medicine, Osaka University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and Intensive Care Medicine, Osaka University
Suita, Osaka, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.